Home‐based fecal calprotectin utilization in a general pediatric gastroenterology clinic
Journal of Pediatric Gastroenterology and Nutrition · 2024
DOI: 10.1002/jpn3.12150 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2024. Verfasst von Melanie L Schmidt und 10 weiteren Autor:innen. Beteiligte Einrichtung: Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. Hauptthemen laut MEDLINE: Gastroenterology, Inflammatory Bowel Diseases, Gastrointestinal Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: AbbVie.
Abstract (Originalsprache)
Objective
Remote investigation and monitoring have gained importance in ambulatory practice. A home‐based fecal calprotectin (FC) test has been developed where the sample is processed and analyzed at home through a smartphone application. We aimed to assess the use of standard ELISA (sFC) versus home‐based (hFC) FC testing in a general pediatric gastroenterology clinic.
Methods
Ambulatory pediatric patients with hFC or sFC performed between August 2019 and November 2020 were included. Data regarding demographics, clinical characteristics, medication use, investigations, and final diagnosis, categorized as inflammatory bowel disease (IBD), functional gastrointestinal (GI) disorders, organic non‐IBD (ONI) GI disorders, non‐GI disorders, and undetermined after 6 months of investigation, were recorded.
Results
A total of 453 FC tests from 453 unique patients were included. Of those, 249 (55%) were hFC. FC levels (median) were higher in children with IBD compared to non‐IBD diagnosis (sFC 795 vs. 57 μg/g, hFC 595 vs. 47 μg/g, p < 0.001), and in ONI compared to functional GI disorders (sFC 85 vs. 54 μg/g, p = 0.003, hFC 57 vs. 40 μg/g, p < 0.001). No significant difference was observed between different ONI GI disorders or subtypes of functional disorders. Age did not significantly influence levels.
Conclusions
Overall, hFC and sFC provide similar results in the general pediatric GI ambulatory setting. FC is a sensitive but not disease‐specific marker to identify patients with IBD. Values appear to be higher in ONI GI disorders over functional disorders, although cut‐off values have yet to be determined.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
- Department of Pediatrics, Division of Pediatric Gastroenterology & Hepatology, Children's Hospital of Western Ontario, London Health Sciences Center, London, Ontario, Canada.
- Children's Health Research Institute, London, Ontario, Canada.
- Lawson Health Research Institute, London, Ontario, Canada.
ORCID-Profile: Melanie L Schmidt
Förderung
- AbbVie
Zitieren
APA
Schmidt, M. L., McCrady, E., Lee, A., Bowerbank, T., Miller, M. R., Watson, M., Dhandapani, A., Woolfson, J. P., Zizzo, A. N., Bax, K., & Crowley, E. (2024). Home‐based fecal calprotectin utilization in a general pediatric gastroenterology clinic. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.12150
Vancouver
Schmidt ML, McCrady E, Lee A, Bowerbank T, Miller MR, Watson M, et al. Home‐based fecal calprotectin utilization in a general pediatric gastroenterology clinic. Journal of Pediatric Gastroenterology and Nutrition. 2024. doi:10.1002/jpn3.12150
BibTeX
@article{Schmidt2024,
author = {Schmidt, Melanie L and McCrady, Emma and Lee, Angus and Bowerbank, Terrence and Miller, Michael R and Watson, Melanie and Dhandapani, Ashok and Woolfson, Jessica P and Zizzo, Andréanne N and Bax, Kevin and Crowley, Eileen},
title = {Home‐based fecal calprotectin utilization in a general pediatric gastroenterology clinic},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2024},
doi = {10.1002/jpn3.12150}
}
EUVIMED